Tuesday, 21st February 2023
15:00 |
Welcome Address and Introduction to the Experts Sanjay Bajaj, CEO & MD, Glostem Private Limited, India
|
15:10 |
From Simple to Complex: The diversity and range of CRISPR applications Eric Rhodes, CEO, ERS Genomics, USA
|
15:35 |
CRISPR/Cas9: Global Licensing Landscape Michael Arciero, Vice President IP & Commercial Development, ERS Genomics, USA
|
16:00 |
CRISPR Engineered Cell Models for Drug Discovery Jun Zhou, Senior Scientist, Crown Biosciences, China
|
16:25 |
Role of BIRAC in Nurturing Biotech Start-up Ecosystem Vinita Jindal, Chief Manager-IP & Technology Management, BIRAC, A Government of India Enterprise, India
|
16:50 |
Closing Remarks Eric Rhodes, CEO, ERS Genomics, USA
|
16:55 |
Vote of Thanks Sanjay Bajaj, CEO & MD, Glostem Private Limited, India
|